The artemisinin derivatives must be in France the first-line treatment of all P. falciparum malaria cases simple or severe;Les dérivés de l'artémisinine doivent être, en France, le traitement de 1ère intention de tous les paludismes à P. falciparum simples ou graves!

Revue du Praticien

Volumn 63, Issue 7, 2013, Pages 896-898

  Danis, Martin ^a   Jauréguiberry, Stéphane ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN DERIVATIVE;

ARTICLE; DISEASE SEVERITY; FRANCE; MALARIA FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; FRANCE; HUMANS; MALARIA, FALCIPARUM; SEVERITY OF ILLNESS INDEX;

EID: 84885453354     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Van Agtmael M, Bouchaud O, Malvy D, et al. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. Int J Antimicrob Agents 1999,12:159-69. (Pubitemid 29276920)
2. Bouchaud O, Mühlberger N, PAROLA P, et al. Therapy of uncomplicated falciparum malaria in Europe : MALTHER - a prospective observational multicentre study. Malar J 2012;11:212.
3. Askling HH, Bruneel F, Burchard G, et al.; European Society for Clinical Microbiology and Infectious Diseases Study Group on Clinical Parasitology. Management of imported malaria in Europe. Malar J 2012;11:328.
4. Keating GM. Dihydroartemisinin/Piperaquine : a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria. Drugs 2012,72:937-61.
5. Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria : a randomised trial. Lancet 2005;366 717-25.
6. Dondorp AM, Fanello CI, Hendriksen IC, et al.; AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT) : an open-label, randomised trial. Lancet 2010;376:1647-57.
7. Zoller T, Junghanss T, Kapaun A, et al. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 2011;17:771-7.
8. Jaureguiberry S, Kendjo É, Ndour A, Thellier M, Buffet P. Traitement par l'artésunate intraveineux en France. Lettre Infectiologue 2012;27 20-8.
9. www.hcspfr/explore.cgi/telecharger/hcspr20130201-palugraveartesunate.pdf